1-14 of 14
John Galvin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Socioeconomic Factors on Access to and Outcomes of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) for Acute Myeloid Leukemia (AML): A Multi-Center Observational Study

Natalie Wuliji, Ted Gooley, Salene Jones, Aaron T. Gerds, Bruno Medeiros, Paul J. Shami, John Galvin, Kehinde Adekola, Selina Luger, Maria R. Baer, David A. Rizzieri, Tanya M. Wildes, Eunice S. Wang, Mikkael A. Sekeres, Sudipto Mukherjee, Julie C. Smith, Mitchell A. Garrison, Kiarash Kojouri, Jacob S. Appelbaum, Mary-Elizabeth M. Percival, Brenda M. Sandmaier, Frederick R. Appelbaum, Mohamed Sorror
Journal: Blood
Blood (2024) 144 (Supplement 1): 6.
https://doi.org/10.1182/blood-2024-202664
Published: 2024
Journal Articles

Real-World Patient Characteristics and Treatment Patterns in Patients with Chronic Graft-Versus-Host Disease Receiving Belumosudil in the United States

Jingbo Yu, Kristin J. Moore, Nicole M. Engel-Nitz, Mary DuCharme, Britnie Thomas, John Galvin, Valkal Bhatt
Journal: Blood
Blood (2024) 144 (Supplement 1): 3522.
https://doi.org/10.1182/blood-2024-208047
Published: 2024
Journal Articles

Real-World Ruxolitinib and Corticosteroid Treatment Patterns in Patients with Chronic Graft-Versus-Host Disease in the United States

Jingbo Yu, Kristin J. Moore, Nicole M Engel-Nitz, Mary DuCharme, John Galvin, Valkal Bhatt, Catherine J. Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 4900.
https://doi.org/10.1182/blood-2024-200781
Published: 2024
Journal Articles

Real-World Effectiveness of Tafasitamab (Tafa) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) in the United States

Kimberly Saverno, Loretta Nastoupil, Bruce Feinberg, John Galvin, Prathamesh Pathak, Theresa Amoloja, Danielle Gentile, Parisa Asgarisabet, Narendranath Epperla
Journal: Blood
Blood (2024) 144 (Supplement 1): 2375.
https://doi.org/10.1182/blood-2024-193264
Published: 2024
Journal Articles

Trial in Progress: Patient-Reported Outcome Measures in the Prospective Observational Cohort Study of Patients at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

Doris M. Ponce, Areej El-Jawahri, Betty K. Hamilton, Nandita Khera, Valkal Bhatt, John Galvin, Catherine J. Lee
Journal: Blood
Blood (2023) 142 (Supplement 1): 7035.
https://doi.org/10.1182/blood-2023-178073
Published: 2023
Journal Articles

Real-World Use of Tafasitamab (tafa) for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Among Racial and Ethnic Minorities in the United States

Narendranath Epperla, Loretta J. Nastoupil, Kristin M. Zimmerman Savill, Bruce Feinberg, John Galvin, Prathamesh Pathak, Sarah Gordon, Theresa Amoloja, Mae Llorente, Kimberly Saverno
Journal: Blood
Blood (2023) 142 (Supplement 1): 2415.
https://doi.org/10.1182/blood-2023-173456
Published: 2023
Journal Articles

Janus Kinase (JAK) 1 Inhibition Results in Significant Changes in Serum Proteins and Peripheral T-Cell Populations That Correlated with Clinical Scores in Chronic Graft Versus Host Disease (GVHD) Patients (an Analysis from GRAVITAS-309)

Michael Pratta, Angelina Volkova, Maureen Bleam, Rodica Morariu-Zamfir, Beth Rumberger, Stephen Douglass, Susan H. Smith, Valkal Bhatt, John Galvin, Annie Im, Sophie Paczesny, Kirk R. Schultz, Steven Z. Pavletic
Journal: Blood
Blood (2023) 142 (Supplement 1): 2197.
https://doi.org/10.1182/blood-2023-174955
Published: 2023
Journal Articles

Tafasitamab for the Treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the US Real-World Setting

Kimberly Saverno, Kristin M. Zimmerman Savill, Bruce Feinberg, John Galvin, Prathamesh Pathak, Sarah Gordon, Theresa Amoloja, Mae Llorente, Narendranath Epperla, Loretta J. Nastoupil
Journal: Blood
Blood (2023) 142 (Supplement 1): 265.
https://doi.org/10.1182/blood-2023-173143
Published: 2023
Journal Articles

Early Versus Late Treatment with Ruxolitinib in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease: A Post Hoc Analysis from the Randomized, Phase 3 REACH3 Study

Robert Zeiser, Zhenyi Xue, Valkal Bhatt, John Galvin, Franco Locatelli
Journal: Blood
Blood (2022) 140 (Supplement 1): 10507–10508.
https://doi.org/10.1182/blood-2022-170186
Published: 2022
Journal Articles

Early Versus Late Treatment with Ruxolitinib in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease: A Post Hoc Analysis from the Randomized Phase 3 REACH2 Study

Gérard Socié, Zhenyi Xue, Valkal Bhatt, John Galvin, Mohamad Mohty
Journal: Blood
Blood (2022) 140 (Supplement 1): 4765–4766.
https://doi.org/10.1182/blood-2022-169717
Published: 2022
Journal Articles

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Clinical Trials & Observations
Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksandr Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai-Ho, Rohtesh Mehta, Trent Wang, Mukta Arora, Iskra Pusic, Ayman Saad, Nirav N. Shah, Sunil Abhyankar, Carlos Bachier, John Galvin, Annie Im, Amelia Langston, Jane Liesveld, Mark Juckett, Aaron Logan, Levanto Schachter, Asif Alavi, Dianna Howard, Harlan W. Waksal, John Ryan, David Eiznhamer, Sanjay K. Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R. Blazar, Steven Pavletic
Journal: Blood
Blood (2021) 138 (22): 2278–2289.
https://doi.org/10.1182/blood.2021012021
Published: 2021
Includes: Supplemental data
Journal Articles

Disability Associated with Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

Betty K. Hamilton, Paul Williams, Giulio Flore, John Galvin, James Turnbull, Jingbo Yu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4060.
https://doi.org/10.1182/blood-2021-153201
Published: 2021
Journal Articles

Assessment Of The Hematopoietic Cell Transplantation Comorbidity Index In Older Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation

Chandra Keebler, MD, Joanne Monreal, AAS, Jessica K Altman, MD, Olga Frankfurt, MD, Leo I. Gordon, MD, John Galvin, MD, MPH, Jayesh Mehta, MD
Journal: Blood
Blood (2013) 122 (21): 5506.
https://doi.org/10.1182/blood.V122.21.5506.5506
Published: 2013
Journal Articles

Organ System Involvement and Mortality In Acute Graft-Versus-Host Disease

Amanda Champlain, MD, Daniel Bach, MD, Dennis West, PhD, John Galvin, MD, MPH, Jayesh Mehta, MD, Jonathan Cotliar, MD
Journal: Blood
Blood (2013) 122 (21): 5479.
https://doi.org/10.1182/blood.V122.21.5479.5479
Published: 2013